Chemistry:Etisulergine
From HandWiki
Etisulergine (INN; developmental code name CQ-32084 or CQ 32-084) is a drug of the ergoline family described as a dopamine agonist, prolactin inhibitor, and antiparkinsonian agent which was never marketed.[1][2][3][4][5][6] It is closely related in chemical structure to lisuride and is also similar in structure to lysergic acid diethylamide (LSD).[1][2] Etisulergine was first described in the literature by at least 1977.[1][5]
See also
- Disulergine
- Mesulergine
- Quinagolide
References
- ↑ 1.0 1.1 1.2 The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014. pp. 524. ISBN 978-1-4757-2085-3. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA524. Retrieved 30 June 2025.
- ↑ 2.0 2.1 Organic-chemical Drugs and Their Synonyms: An International Survey. Wiley-VCH. 2001. pp. 1829. ISBN 978-3-527-30247-5. https://books.google.com/books?id=zmpqAAAAMAAJ. Retrieved 30 June 2025.
- ↑ Drugs: Synonyms and Properties: Synonyms and Properties. Routledge. 8 May 2018. ISBN 978-1-351-78989-9. https://books.google.com/books?id=xUlaDwAAQBAJ&pg=PT1299. Retrieved 30 June 2025.
- ↑ "Perspectives in the design and application of dopamine receptor agonists". Pharmacochemistry Library. 24. Elsevier. 1996. pp. 67–84. doi:10.1016/s0165-7208(96)80008-0. ISBN 978-0-444-82204-8. https://linkinghub.elsevier.com/retrieve/pii/S0165720896800080. Retrieved 30 June 2025.
- ↑ 5.0 5.1 "Two novel prolactin release-inhibiting 8 alpha-amino-ergolines". Experientia 35 (12): 1677–1678. December 1979. doi:10.1007/BF01953267. PMID 520501.
- ↑ "Treatment of Parkinson's disease with the ergoline derivatives CQ 32-084 and CU 32-085". Advances in Neurology 37: 151–157. 1983. PMID 6344587.
 |  |
